Crystal structure of vismodegib, C19H14Cl2N2O3S

被引:1
|
作者
Kaduk, James A. [1 ,2 ]
Gates-Rector, Stacy [3 ]
Blanton, Thomas N. [3 ]
机构
[1] IIT, 3101 S Dearborn St, Chicago, IL 60616 USA
[2] North Cent Coll, 131 S Loomis St, Naperville, IL 60540 USA
[3] ICDD, 12 Campus Blvd, Newtown Sq, PA 19073 USA
关键词
vismodegib; Erivedge; crystal structure; Rietveld refinement; density functional theory; VALIDATION; PATTERNS; DENSITY;
D O I
10.1017/S0885715622000446
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
The crystal structure of vismodegib has been solved and refined using synchrotron X-ray powder diffraction data, and optimized using density functional theory techniques. Vismodegib crystallizes in space group P2(1)/a (#14) with a = 16.92070(20), b = 10.20235(4), c = 12.16161(10) angstrom, beta = 108.6802(3)degrees, V = 1988.873(9) angstrom(3), and Z = 4. The crystal structure consists of corrugated layers of molecules parallel to the bc-plane. There is only one classical hydrogen bond in the structure, between the amide nitrogen atom and the N atom of the pyridine ring. Pairs of these hydrogen bonds link the molecules into dimers, with a graph set R2,2(14) > a > a. The powder pattern has been submitted to ICDD for inclusion in the Powder Diffraction File (TM) (PDF (R)).
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [21] Crystal structure of minocycline hydrochloride dihydrate form A, C23H28N3O7Cl (H2O)2
    Wheatley, Austin M.
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2019, 34 (01) : 59 - 65
  • [22] Crystal structure of tezacaftor Form A, C26H27F3N2O6
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2021, 36 (01) : 56 - 62
  • [23] Crystal structure of imepitoin, C13H14ClN3O2
    Kaduk, James A.
    Gindhart, Amy M.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (04) : 206 - 210
  • [24] Crystal structure of sparsentan, C32H40N4O5S
    Kaduk, James A.
    Dosen, Anja
    Blanton, Thomas
    POWDER DIFFRACTION, 2025,
  • [25] Crystal structure of tramadol hydrochloride, C16H26NO2Cl
    Kaduk, James A.
    Zhong, Kai
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2015, 30 (03) : 242 - 249
  • [26] Crystal structure of oxibendazole, C12H15N3O3
    Kaduk, James A. A.
    Gates-Rector, Stacy
    Blanton, Thomas N. N.
    POWDER DIFFRACTION, 2023, 38 (01) : 15 - 20
  • [27] Crystal structure of alectinib hydrochloride Type I, C30H35N4O2Cl
    Kaduk, James A.
    Rost, Megan M.
    Dosen, Anja
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2024, 39 (03) : 170 - 175
  • [28] Crystal structure of besifloxacin hydrochloride, C19H22ClFN3O3Cl
    Kaduk, James A.
    Gates-Rector, Stacy
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2023, 38 (01) : 43 - 52
  • [29] Crystal structure of cephalexin monohydrate, C16H17N3O4S(H2O)
    Kaduk, James A.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2020, 35 (04) : 293 - 300
  • [30] Crystal structure of fulvestrant hydrate (ethyl acetate), C32H47F5O3S(H2O)0.16(C4H8O2)0.025
    Kaduk, James A.
    Boaz, Nicholas C.
    Gates-Rector, Stacy D.
    Gindhart, Amy M.
    Blanton, Thomas N.
    POWDER DIFFRACTION, 2022, 37 (03) : 157 - 165